018474196

NORTHERA

---

May 17, 2021

Trademark Summary

The trademark application NORTHERA was filed by H. Lundbeck A/S, a corporation established under the laws of the Kingdom of Denmark (the "Applicant"). The application was published for oppositions on June 13, 2021, and it was registered by office on September 20, 2021 without any oppositions.

The application was filed in Danish (English was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Pharmaceuticals and medical preparations and substances
  2. Vaccines
  3. Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system
  4. Pharmaceutical preparations and substances acting on the central nervous system
  5. Central nervous system stimulants
  6. Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases
  7. Pharmaceutical preparations and substances used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, dementia, Alzheimer's disorder and disease, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease
  8. Pharmaceutical preparations and substances used for the prevention, management and treatment of falls, movement disorders and diseases, dyskinesia
  9. Poor or absent motor functions, tremor, schizophrenia, bipolar disorder and disease, mania, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), agitation, aggression, autism, melancholy, obsessive-compulsive disorder (OCD), Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, alcoholism and dependency
  10. Pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension (NOH), low blood pressure, dizziness, lightheadedness gait stiffness
  11. Preparations, substances, reagents and agents for diagnostic and medical purposes.